Germline BRCA mutation evaluation in a prospective triple-negative breast cancer registry: implications for hereditary breast and/or ovarian cancer syndrome testing

NCCN guidelines recommend genetic testing for all triple-negative breast cancer (TNBC) patients aged ≤60 years. However, due to the lack of prospective information in unselected patients, these guidelines are not uniformly adopted by clinicians and insurance carriers. The aim of this study was to de...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Sharma, Priyanka, Klemp, Jennifer R., Kimler, Bruce F., Mahnken, Jonathan D., Geier, Larry J., Khan, Qamar J., Elia, Manana, Connor, Carol S., McGinness, Marilee K., Mammen, Joshua M. W., Wagner, Jamie L., Ward, Claire, Ranallo, Lori, Knight, Catherine J., Stecklein, Shane R., Jensen, Roy A., Fabian, Carol J., Godwin, Andrew K.
Formato: Artigo
Idioma:Inglês
Publicado em: 2014
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4171847/
https://ncbi.nlm.nih.gov/pubmed/24807107
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s10549-014-2980-0
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados